Tag: patent litigation
Patent Litigation and Generic Entry: Why Disputes Delay Life-Saving Medications
Mar, 23 2026
Patent litigation in the pharmaceutical industry routinely delays generic drug launches by years, keeping prices high and patients without affordable options. The system was designed to balance innovation and competition - but now it mostly protects profits.
Read Article→
30-Month Stay: How Litigation Delays Generic Drug Approval
Dec, 11 2025
The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by filing patent lawsuits. This legal tool, meant to protect innovation, often extends drug monopolies by years-costing patients billions.
Read Article→
Patent Litigation: How Authorized Generics Undermine Generic Competition
Nov, 27 2025
Authorized generics let brand drug makers launch their own cheaper versions right when independent generics enter the market, undermining price competition and reducing incentives for patent challenges. This practice hurts patients and generic manufacturers - and regulators are fighting back.
Read Article→